dichlororibofuranosylbenzimidazole has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qu, LY | 1 |
| Jiang, YL | 1 |
| Tang, XW | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
[Effect of DRB/alpha-Amanitin on localization of Nrf2 in A549 cells].
Topics: 20-Hydroxysteroid Dehydrogenases; Alpha-Amanitin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; | 2010 |